MedPath

Clinical study on treatment of primary headache with liver-yang hyperactivity syndrome by He-Sea acupoints

Phase 1
Recruiting
Conditions
Primary headache
Registration Number
ITMCTR2100004357
Lead Sponsor
The Second Affiliated Hospital of Shandong University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the diagnostic criteria of Western medicine and traditional Chinese medicine for primary headache;
2. Patients aged 18-70 years old;
3. Male and female are not limited;
4. Patients who have not received all kinds of treatment measures related to the disease in recent one month;
5. The patients who signed the informed consent form voluntarily participated in and obeyed the arrangement of the research group and insisted on completing the treatment.

Exclusion Criteria

1. Pregnant or lactating women;
2. Patients suffering from diseases of important organs or other diseases that may seriously endanger life;
3. Patients with headache but accompanied by other diseases, such as post-traumatic brain syndrome and brain organic lesions;
4. Patients with acupuncture sickness or allergic constitution.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TCCD;VAS;Headache symptom score;
Secondary Outcome Measures
NameTimeMethod
SF-36;
© Copyright 2025. All Rights Reserved by MedPath